SEP 24, 2018 10:01 PM PDT

Protein Serves as a Potential Drug Target

WRITTEN BY: Nouran Amin

Image via Phys.org

Researchers at Van Andel Research Institute (VARI) have shown an atomic-level structure of a protein that may serve as a future drug target for conditions like Alzheimer's disease and bipolar disorder.

The protein, known as TRPM2, was found throughout the body to integrally be involved in body temperature regulation, immune response mediation, and governing the programmed death of cells (apoptosis).

TRPM2 belongs to the TRP superfamily of proteins that work to mediate responses to sensory stimuli, inclduing pain, pressure, vision, temperature and taste.

"TRPM2 is absolutely critical for healthy function but, until today, we were missing key insights into its structure and mechanism of action," says Juan Du, Ph.D., an assistant professor at VARI. "It is our hope that these findings will act as a schematic for designing better and desperately needed medications for a host of neurological conditions." It is now the first protein to be pictured at the atomic level.

Image via Drug Target Review

The images of TRPM2 on the atomic level have illustrated a “bell-like structure, with a transmembrane domain region on the bell's shoulder and an expanded NUDT9-H domain on the bell's lip”. Images also revela the bindg site for ADPR, the messenger molecule associated with oxidative stress and metabolism. "Although we have known for some time that TRPM2 is a vital component of many biological processes and a possible drug target, we didn't know exactly what it looked like or how it worked," said Wei Lü, Ph.D., an assistant professor at VARI and co-senior author. "Today's findings change that, and go a long way toward a more comprehensive understanding of these incredibly important molecules."

About the Author
  • Nouran enjoys writing on various topics including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
JUL 13, 2018
Drug Discovery
JUL 13, 2018
Pharmacological Strategy Attempts To Treat Multiple Symptoms of Fragile X
Recent research in a mouse model of fragile X syndrome (FXS), scheduled for publication in Neuropsychopharmacology, shows that a pharmacological strategy c...
JUL 24, 2018
Drug Discovery
JUL 24, 2018
Reversing Symptoms of Aging in Mice Inspires Anti-Aging Drugs
It would be a breakthrough for science if symptoms of aging were reversed in humans. Well, researchers at the University of Alabama at Birmingham have turn...
AUG 25, 2018
Videos
AUG 25, 2018
Engineering Targeted Nanoparticles
The Koch Institute at MIT has chosen one of Jason Chang's images as an Image Award recipient for 2018....
SEP 23, 2018
Cell & Molecular Biology
SEP 23, 2018
Insulin may be a new Colitis Treatment
Insulin is a necessary medicine for diabetics, but new work shows that insulin may also be used to treat chronic bowel inflammation....
OCT 06, 2018
Drug Discovery
OCT 06, 2018
New Class of Drugs for Breast Cancer Therapy
Scientists at Stevens Institute of Technology have designed a new class of molecules that may hold the potential to add to the arsenal of drugs actively be...
OCT 16, 2018
Neuroscience
OCT 16, 2018
Your brain tells if a placebo can treat pain
Placebo effect and predicting when a particular subject will have a placebo response by using as little as psychological questionnaires....
Loading Comments...